New-onset pemphigus foliaceus following SARS-CoV-2 infection and unmasking multiple sclerosis: A case report.

Fatemeh Mohaghegh Parvaneh HatamiArezoo RefaghatMohammadjavad MehdizadehZeinab AryanianNessa Aghazadeh MohandesiZeinab Mohseni Afshar

Published in: Clinical case reports (2022)

Development of pemphigus foliaceus (PF) following SARS-CoV-2 infection has only been reported in one patient who had received Bamlanivimab and thus might be considered as a drug-induced case of PF. Here, we reported the first case of PF arising solely after COVID infection without taking any culprit drug.

Keyphrases

drug induced
liver injury
multiple sclerosis
respiratory syndrome coronavirus
adverse drug
case report
sars cov
white matter
coronavirus disease